Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-016931

President and CEO sold 18,333 shares at an average $22.18 ($406,601)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2019-03-01 Sale −4,000 $22.19 $88,760 2,630,304 I
Watts Ryan J. President and CEO 2019-03-01 Sale −2,050 $22.91 $46,966 2,628,254 I
Watts Ryan J. President and CEO 2019-03-04 Sale −4,442 $21.87 $97,147 2,623,812 I
Watts Ryan J. President and CEO 2019-03-04 Sale −1,700 $22.83 $38,811 2,622,112 I
Watts Ryan J. President and CEO 2019-03-05 Sale −6,141 $21.97 $134,918 2,615,971 I
Open-market sales · 18,333 sh · avg $22.18 · $406,601
Loading xslF345X03/doc4.xml…